Genmab A GNMSF
NASDAQ GNMSF
$337.00 +2.00 (+0.60%)
As of: Aug 21, 2026 · 10:11 AM EDT

Genmab A/S (GNMSF) Cash from Discontinued Operations (2020 - 2025)

Genmab A's (GNMSF) quarterly Cash from Discontinued Operations came in at 287000000.0 in Q1 2025, up 31.05% YoY from 219000000.0 in Q1 2024, and down 94.33% on a QoQ basis from 5059000000.0 in Q3 2024.

Genmab A/S (GNMSF) Cash from Discontinued Operations (2020 - 2025) Analysis & Trends

Genmab A (GNMSF) has 4 years of Cash from Discontinued Operations data on file, last reported at 287000000.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2025 287.00 Mn
Mar 31, 2025 287.00 Mn
Sep 30, 2024 5.06 Bn
Sep 30, 2024 5.06 Bn
Mar 31, 2024 219.00 Mn
Mar 31, 2024 219.00 Mn
Mar 31, 2021 1.19 Bn
Mar 31, 2021 1.19 Bn
Mar 31, 2020 1.91 Bn
Mar 31, 2020 1.91 Bn